Physician Advice for e-Cigarette Use

Kollath-Cattano, Christy; Thrasher, James F.; Osman, Amira; Andrews, Jeannette O.; Strayer, Scott M.

doi:10.3122/jabfm.2016.06.160092

Cited by 21 publications

(36 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…26 Marketing contributes to perceived knowledge regarding the health and safety of e-cigarettes 28 , and in our sample, participants heard about e-cigarettes from the media, family or friends, and e-cigarette (vape) shops, but very few heard about them from physician offices, which is consistent with other research. 29 These findings underscore the need for PCPs to be able to provide patients with accurate information on these products rather than relying on potentially biased and profit-driven sources of information.…”

Section: Discussionmentioning

confidence: 99%

Patient Perspectives on Discussions of Electronic Cigarettes in Primary Care

et al. 2018

View full text Add to dashboard Cite

Purpose: Patient preferences regarding the role of the primary care provider (PCP) in discussing electronic cigarette (e-cigarette) use are unknown.Methods: We administered a cross-sectional survey to 568 adult patients in a family medicine clinic to explore e-cigarette use, sources of information on e-cigarettes, perceived knowledge about e-cigarette health effects, views regarding PCP knowledge of e-cigarettes, interest in discussing e-cigarettes with PCPs and preferred format for e-cigarette information. We performed 2 testing with a 2-tailed P < .05 to assess associations between e-cigarette use and these measures.Results: The prevalence of e-cigarette use was 10% for recent (<30 days) use and 29% for nonrecent (>30 days) use. Prevalence was significantly higher among those who were younger, less educated, or smoked cigarettes, but did not vary by sex or self-reported health status. Roughly one quarter of participants believed they were knowledgeable about the health effects of e-cigarettes, secondhand smoke, and quitting cigarettes. Sources of e-cigarette information included television advertisements (56.6%), friends and family (49.9%), or e-cigarette shops (25.5%), but included physician offices much less frequently (6.0%). Although 30.2% disagreed that their PCP knew a lot about e-cigarettes, 62.0% were comfortable discussing e-cigarettes with their PCP. However, only 25% of all patients wanted their PCP to discuss e-cigarettes with them, but 62.0% of recent e-cigarette users wanted such a discussion. Most preferred a brief discussion or handout to a lengthy discussion.

show abstract

Section: Discussionmentioning

confidence: 99%

Patient Perspectives on Discussions of Electronic Cigarettes in Primary Care

et al. 2018

View full text Add to dashboard Cite

show abstract

“…These studies have indicated that dialogues about NVPs have become increasingly frequent in clinical settings , are generally initiated by the patient , and typically do not end in a recommendation to use NVPs, apparently because most providers remain neutral or advise against use . To the best of our knowledge, only two studies have examined patient–physician NVP discussions from the patient's perspective . One online study in the United States by Berg et al .…”

Section: Introductionmentioning

confidence: 99%

Discussions between health professionals and smokers about nicotine vaping products: results from the 2016 ITC Four Country Smoking and Vaping Survey

et al. 2019

View full text Add to dashboard Cite

Background and Aims: Debate exists about whether health professionals (HPs) should advise smokers to use nicotine vaping products (NVPs) to quit smoking. The objectives were to examine in four countries: (1) the prevalence of HP discussions and recommendations to use an NVP; (2) who initiated NVP discussions; (3) the type of HP advice received about NVPs; and (4) smoker’s characteristics related to receiving advice about NVPs. Design: Cross-sectional study using multivariable logistic regression analyses on weighted data from the 2016 ITC Four Country Smoking and Vaping Survey (ITC 4CV1). Setting: Four countries with varying regulations governing the sale and marketing of NVPs: ‘most restrictive’ (Australia), ‘restrictive’ (Canada) or ‘less restrictive’ (England and United States). Participants: A total of 6615 adult smokers who reported having visited an HP in the last year (drawn from the total sample of 12 294 4CV1 respondents, of whom 9398 reported smoking cigarettes daily or weekly). Respondents were from the United States (n = 1518), England (n = 2116), Australia (n = 1046), and Canada (n = 1935). Measurements: Participants’ survey responses indicated if they were current daily or weekly smokers and had visited an HP in the past year. Among those participants, further questions asked participants to report (1) whether NVPs were discussed, (2) who raised the topic, (3) advice received on use of NVPs and (4) advice received on quitting smoking. Findings: Among the 6615 smokers who visited an HP in the last year, 6.8% reported discussing NVPs with an HP and 2.1% of smokers were encouraged to use an NVP (36.1% of those who had a discussion). Compared with Australia (4.3%), discussing NVPs with an HP was more likely in the United States [8.8%, odds ratio (OR) = 2.15, 95% confidence interval (CI) = 1.41–3.29] and Canada (7.8%, OR = 1.87, 95% CI = 1.26–2.78). Smokers in Australia were less likely to discuss NVPs than smokers in England (6.2%), although this was not statistically significant (OR = 1.47, 95% CI = 0.98–2.20). Overall, the prevalence of HPs recommending NVPs was three times more likely in the United States than in Australia (OR = 3.07, 95% CI = 1.45–6.47), and twice as likely in Canada (OR = 2.28, 95% CI = 1.06–4.87) than in Australia. Australia and England did not differ (OR = 1.76, 95% CI = 0.83–3.74). Just over half (54%) of respondents brought up NVPs themselves; there were no significant differences among countries. Conclusions: Discussions in Australia, Canada, England, and the United States between smokers and health professionals about nicotine vaping products appear to be infrequent, regardless of the regulatory environment. A low percentage of health professionals recommended vaping products. This was particularly evident in Australia, which has the most restrictive regulatory environment of the four countries studied.

show abstract

“…Based on the current study, moreover, clinical advice and public health efforts to reduce illness related to smoking may need to be aware of different beliefs in different parts of the country so as to be able to effectively tailor messages. A national online study of smokers conducted in a similar timeframe as the 2015 TUS‐CPS data collection found that 15% of respondents discussed e‐cigarettes with their physicians, among whom 61% were advised to try e‐cigarettes as a smoking cessation aid . With reduced access to health care in rural areas, the burden for education falls more heavily on public health and policy advocates, distinguishing messages for never, current, and former smokers to maximize public health benefits …”

Section: Discussionmentioning

confidence: 99%

“…A national online study of smokers conducted in a similar timeframe as the 2015 TUS-CPS data collection found that 15% of respondents discussed e-cigarettes with their physicians, among whom 61% were advised to try e-cigarettes as a smoking cessation aid. 43 With reduced access to health care in rural areas, 9 the burden for education 25 falls more heavily on public health and policy advocates, distinguishing messages for never, current, and former smokers to maximize public health benefits. 44 There are several important factors that may affect developing patterns of e-cigarette use and beliefs in rural regions.…”

Section: Discussionmentioning

confidence: 99%

Regional Rural‐Urban Differences in E‐Cigarette Use and Reasons for Use in the United States

Mumford

Stillman

Tanenbaum

et al. 2018

The Journal of Rural Health

View full text Add to dashboard Cite

Purpose To determine whether there are rural/urban differences in e‐cigarette use and reasons for use that vary across the 10 Health & Human Services (HHS) regions. Methods Age‐adjusted bivariate and multivariable analyses were conducted for n = 225,413 respondents to the 2014–2015 Tobacco Use Supplement‐Current Population Survey to estimate the prevalence of e‐cigarette use. Reasons for e‐cigarette use were collected from n = 16,023 self‐respondents who reported ever using e‐cigarettes. Findings While nationally rural residents appeared more likely to use e‐cigarettes, adjusted results indicated that current e‐cigarette use was significantly less likely across the northern and western regions (New England, East North Central, Heartland, North Central Mountain, Northwest, and Southwest Pacific regions). Reasons for e‐cigarette use differed by urban/rural status and region; for example, the rationale to use e‐cigarettes as a smoking cessation aid was significantly more common among rural compared to urban adults in the New England and New York/New Jersey regions, but less common in the Southeast. Conclusions For several regions, there were no significant rural/urban differences in e‐cigarette use and reasons for use. Yet those regions that present differences face the need to develop public health approaches to minimize urban/rural disparities in health education, services, and outcomes related to tobacco use, particularly where access to health care is limited. Public health campaigns and guidance for clinical care within HHS regions should be tailored to reflect regional differences in beliefs about e‐cigarettes.

show abstract

Physician Advice for e-Cigarette Use

Cited by 21 publications

References 12 publications

Patient Perspectives on Discussions of Electronic Cigarettes in Primary Care

Patient Perspectives on Discussions of Electronic Cigarettes in Primary Care

Discussions between health professionals and smokers about nicotine vaping products: results from the 2016 ITC Four Country Smoking and Vaping Survey

Regional Rural‐Urban Differences in E‐Cigarette Use and Reasons for Use in the United States

Contact Info

Product

Resources

About